Search

Full-text search across all signals and tags

2 results for "fda"

MarketsFeatured
8.8

Eli Lilly receives FDA approval for oral weight-loss drug Foundayo

Eli Lilly has obtained US regulatory approval for Foundayo, an oral formulation targeting obesity, intensifying competition with Novo Nordisk's existing pill-based obesity treatments. This approval expands the competitive landscape in the high-growth obesity pharmaceutical market. Market implications include potential pricing pressure and market share redistribution among major pharmaceutical players.

Financial Times·US·about 4 hours ago
Confirmed
USDeveloping
6.6

FDA's Nicotine Pouch Fast-Track Approval Faces Regulatory Delays Over Addiction Risks

The US regulatory approval process for nicotine pouches is experiencing slowdowns due to concerns about youth access and addiction potential in non-smokers. The delays reflect growing scrutiny of whether nicotine pouches represent a public health risk by creating new nicotine users rather than serving as a smoking cessation tool. The outcome will likely influence tobacco product regulation and market access timelines.

Straits Times·US·about 3 hours ago
Corroborating